Acura Pharmaceuticals, Inc. (ACUR)

Acura Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Feb 13, 2026	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Market Capitalization	0	33	5	5	2	8
Market Cap Growth	-99.49%	615.81%	-7.20%	102.71%	-71.23%	-7.41%
Enterprise Value	-	33	10	9	6	7
Last Close Price	0.00	0.50	0.21	0.23	0.11	0.40
PS Ratio	0.02	20.82	1.27	1.84	5.90	2.83
PB Ratio	0.19	182.83	-0.77	-1.03	-0.67	-311.06
P/TBV Ratio	0.19	182.83	-	-	-	-
EV/Sales Ratio	-	20.97	2.89	3.56	13.49	2.44
EV/EBITDA Ratio	-	-	294.93	-	-	-
Debt / Equity Ratio	1.12	1.12	-1.06	-1.27	-1.17	-99.78
Debt / EBITDA Ratio	-	-	179.11	-	-	-
Net Debt / Equity Ratio	0.76	0.76	-0.99	-1.08	-1.14	-17.56
Net Debt / EBITDA Ratio	-0.12	-0.12	167.31	-11.37	-1.14	-0.10
Net Debt / FCF Ratio	-0.18	-0.18	-8.14	-8.31	-1.06	-0.10
Asset Turnover	1.20	1.20	1.66	1.13	0.12	0.46
Quick Ratio	0.43	0.43	0.14	0.98	0.21	0.50
Current Ratio	0.72	0.72	0.16	1.10	0.32	0.55
Return on Equity (ROE)	-	-	-	-	-	-983.05%
Return on Assets (ROA)	-58.45%	-58.45%	-2.62%	-19.23%	-72.44%	-50.98%
Return on Invested Capital (ROIC)	-355.49%	-873.38%	-49.72%	-158.82%	-813.08%	-242.80%
Return on Capital Employed (ROCE)	-351.90%	-351.90%	1.60%	-48.70%	-546.00%	19351.90%
Earnings Yield	-2637.66%	-2.70%	-26.57%	-77.03%	-158.97%	-67.65%
FCF Yield	-	-2.28%	-15.81%	-12.62%	-161.71%	-53.70%
Buyback Yield / Dilution	-75.75%	-75.75%	-20.96%	-26.36%	-32.97%	-33.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.